Annete Njue, PhD

Director, Market Access and Outcomes Strategy

PhD, Molecular Biology
McGill University, Canada

MSc, Applied Parasitology and Medical Entomology
Liverpool University, England

BVM
University of Nairobi, Kenya

Annete Njue, PhD, is a Director in the RTI-HS Market Access and Outcomes Strategy group in Manchester, United Kingdom. She has over 13 years of experience working in market access and medical communications. Dr. Njue is involved in leading and writing systematic and targeted literature reviews and value dossiers to support products in a variety of therapy areas. She is also involved in preparing submissions for the National Institute for Health and Clinical Excellence (NICE) and the Scottish Medicines Consortium (SMC). She has experience in a broad range of therapy areas, including cardiovascular disease, diabetes, hematological disorders, infectious diseases, oncology (breast, lung, prostate, colorectal cancer, myeloma), mental health, ocular conditions, renal disease, reproductive disorders, and respiratory disorders. Before joining RTI-HS, Dr. Njue was a Senior Medical Writer at Prime Medica Ltd. Dr. Njue previously worked in veterinary research in Canada and Kenya, and published her work in Journal of Neurochemistry, Parasitology, and Parasitology Research.